Article
Atractylenolide III predisposes miR-195-5p/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer
2020-08-12
Abstract excerpt
<h4>Background: </h4> Antineoplastic activity of atractylenolide III (ATL) has been reported in several malignant tumors. However, its activity has not been completely clarified in hepatocellular carcinoma (HCC). Herein, anti-cancer effects and underlying molecular mechanisms of ATL were investigated in HCC cells in vitro. <h4>Methods: </h4>: Cell viability was evaluated by CCK-8 assay. Cell migration and invasion...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5c763d1f-e7b6-5599-9efa-3d97e27f77af
- DOI
- 10.21203/rs.3.rs-56832/v1
